Kaplan SA - Search Results

1

A cost-effectiveness analysis of retropubic midurethral sling versus transobturator midurethral sling for female stress urinary incontinence.

Seklehner S, Laudano MA, Te AE, Kaplan SA, Chughtai B, Lee RK. Seklehner S, et al. Among authors: kaplan sa. Neurourol Urodyn. 2014 Nov;33(8):1186-92. doi: 10.1002/nau.22483. Epub 2013 Aug 14. Neurourol Urodyn. 2014. PMID: 23946119

2

PSA response to finasteride challenge in men with a serum PSA greater than 4 ng/ml and previous negative prostate biopsy: preliminary study.

Kaplan SA, Ghafar MA, Volpe MA, Lam JS, Fromer D, Te AE. Kaplan SA, et al. Urology. 2002 Sep;60(3):464-8. doi: 10.1016/s0090-4295(02)01760-0. Urology. 2002. PMID: 12350485 Clinical Trial.

3

A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome.

Kaplan SA, Volpe MA, Te AE. Kaplan SA, et al. J Urol. 2004 Jan;171(1):284-8. doi: 10.1097/01.ju.0000101487.83730.80. J Urol. 2004. PMID: 14665895 Clinical Trial.

4

High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates.

Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. Sandhu JS, et al. Among authors: kaplan sa. Urology. 2004 Dec;64(6):1155-9. doi: 10.1016/j.urology.2004.07.018. Urology. 2004. PMID: 15596189 Clinical Trial.

5

Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia.

Kaplan SA, Walmsley K, Te AE. Kaplan SA, et al. J Urol. 2005 Dec;174(6):2273-5. discussion 2275-6. doi: 10.1097/01.ju.0000181823.33224.a0. J Urol. 2005. PMID: 16280803

6

Photoselective laser vaporization prostatectomy in men receiving anticoagulants.

Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE. Sandhu JS, et al. Among authors: kaplan sa. J Endourol. 2005 Dec;19(10):1196-8. doi: 10.1089/end.2005.19.1196. J Endourol. 2005. PMID: 16359214

7

Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.

Kaplan SA, Gonzalez RR, Te AE. Kaplan SA, et al. Eur Urol. 2007 Jun;51(6):1717-23. doi: 10.1016/j.eururo.2007.01.033. Epub 2007 Jan 16. Eur Urol. 2007. PMID: 17258855 Clinical Trial.

8

Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia.

Kaplan SA, Walmsley K, Te AE. Kaplan SA, et al. J Urol. 2008 May;179(5 Suppl):S82-5. doi: 10.1016/j.juro.2008.03.142. J Urol. 2008. PMID: 18405763

9

Temporal trends in adoption of and indications for the artificial urinary sphincter.

Lee R, Te AE, Kaplan SA, Sandhu JS. Lee R, et al. Among authors: kaplan sa. J Urol. 2009 Jun;181(6):2622-7. doi: 10.1016/j.juro.2009.01.113. Epub 2009 Apr 16. J Urol. 2009. PMID: 19375102

10

Decreasing electrosurgical transurethral resection of the prostate surgical volume during graduate medical education training is associated with increased surgical adverse events.

Sandhu JS, Jaffe WI, Chung DE, Kaplan SA, Te AE. Sandhu JS, et al. Among authors: kaplan sa. J Urol. 2010 Apr;183(4):1515-9. doi: 10.1016/j.juro.2009.12.025. Epub 2010 Feb 20. J Urol. 2010. PMID: 20171700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,015 results

Search Page

Filters